We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodie... Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the US. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR related protein (GITR) and carbonic anhydrase IX (CAIX). It emphasizes on developing novel immuno-oncology and checkpoint inhibitor antibodies as well as oral targeted anti-cancer therapies consisting of an inhibitor of epidermal growth factor receptor (EGFR) mutations, an inhibitor of the bromodomain and extra-terminal (BET) protein, BRD4, and an inhibitor of poly (ADP-ribose) polymerase (PARP). Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0299 | -1.59042553191 | 1.88 | 1.9138 | 1.75 | 233933 | 1.818174 | CS |
4 | 0.4401 | 31.2127659574 | 1.41 | 2.12 | 1.39 | 455111 | 1.74681661 | CS |
12 | -0.3599 | -16.2850678733 | 2.21 | 2.24 | 1.38 | 384017 | 1.77263346 | CS |
26 | -0.6999 | -27.4470588235 | 2.55 | 3.62 | 1.36 | 668881 | 2.07807594 | CS |
52 | -0.9299 | -33.4496402878 | 2.78 | 3.62 | 1.3 | 470564 | 2.1237558 | CS |
156 | -25.1499 | -93.1477777778 | 27 | 46.4 | 1.3 | 630809 | 17.55744829 | CS |
260 | -39.4499 | -95.5203389831 | 41.3 | 53.762 | 1.3 | 614261 | 21.87889859 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions